AWM
GCTK icon

Accurate Wealth Management’s GlucoTrack GCTK Stock Holding History

Accurate Wealth Management’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$18.1K – 331
2024
Q1 		$18.1K Hold
4
– – 0.01% 287
2023
Q4 		$5.53K Hold
4
– – ﹤0.01% 272
2023
Q3 		$5.21K Buy
+4
New +$7.19K ﹤0.01% 270

Other funds holding GCTK

AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Accurate Wealth Management's GCTK Position: Q2 2024 in Review

Accurate Wealth Management sold out of GlucoTrack (GCTK) in Q2 2024, closing a stake of 4 shares — an estimated $18.1K sold.

Accurate Wealth Management first reported a position in GCTK in Q3 2023 and held it in 3 quarters. The position peaked at $18.1K in Q1 2024. 3 funds tracked by Wall St. Rank hold GCTK as of Q2 2024.

  • Accurate Wealth Management reported no remaining GlucoTrack position as of Q2 2024 after selling out during the quarter.
  • Accurate Wealth Management sold 4 GlucoTrack shares in Q2 2024, an estimated $18.1K.
  • Accurate Wealth Management first reported a position in GlucoTrack in Q3 2023 and held it in 3 quarters.
  • Accurate Wealth Management's GlucoTrack position peaked at $18.1K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2024.

Based on Accurate Wealth Management's 13F filing for Q2 2024, filed 17 Jul 2024.